
T Cardi 90mg Tablet
Marketer
Cardimind Pharmaceuticals
Salt Composition
Ticagrelor (90mg)
Overview T Cardi 90mg Tablet
Cardioguard 90mg tablets are classified as antiplatelet agents, commonly known as blood thinners. Their function is to inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of heart attack or stroke in patients with cardiac conditions. Cardioguard 90mg is also indicated for individuals recovering from a recent heart attack, experiencing severe angina (unstable chest pain), or post-stent placement. This medication helps prevent further cardiovascular events, including recurrent heart attacks, strokes, and clot formation within stents. Concurrently, your physician will likely prescribe aspirin, another antiplatelet medication. Cardioguard 90mg can be administered with or without food, consistently at the same time daily. Continuous use is crucial, even in the absence of symptoms, as discontinuation elevates the risk of subsequent heart attacks or strokes. The most frequent adverse effect is bleeding; minor injuries may bleed for an extended period. While usually self-resolving, prolonged or excessive bleeding should be reported. Some individuals experience mild dyspnea (shortness of breath), which typically subsides with continued therapy; however, worsening or persistent dyspnea warrants medical attention. Cardioguard 90mg is contraindicated in individuals with active bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your physician prior to commencing treatment.
Uses of T Cardi 90mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of T Cardi 90mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. T Cardi 90mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of T Cardi 90mg Tablet:
- Bleeding
- Breathlessness
How to use T Cardi 90mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 90mg T Cardi tablet whole; do not alter its form by chewing, crushing, or breaking. While it can be taken with or without food, consistent timing is recommended.
How T Cardi 90mg Tablet works:
CardioGuard 90mg tablets are antiplatelet agents that inhibit platelet aggregation, reducing the risk of dangerous thrombus formation and consequently lowering the likelihood of myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Use of T Cardi 90mg Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of T Cardi 90mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of T Cardi 90mg Tablet while breastfeeding is lacking. Seek your physician's advice.
DrivingSAFE
Driving ability is typically unaffected by T Cardi 90mg Tablets.
KidneySAFE IF PRESCRIBED
T Cardi 90mg tablets can be administered to patients with kidney impairment without altering the dosage. Data regarding T Cardi 90mg tablet use in individuals undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use T Cardi 90mg Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. T Cardi 90mg Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take T Cardi 90mg Tablet :
Should you forget a T Cardi 90mg Tablet dose, take it promptly. If your next dose is imminent, however, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About T Cardi 90mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
